Home

WILFRED E JAEGER

CIK 1190474 · last filed 2023-05-30

WILFRED E JAEGER is a corporate insider who has filed 74 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for STIM, was dated May 30, 2023. Across all open-market trades the lifetime net is −$146.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $399.1K across reported positions. 30 SEC filings were submitted jointly with MARK A WAN.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$399.1K

Companies

8

Total Filings

74

Lifetime Open-Market Net

-$146.64M

Filer Profile

Reported Address
C/O THREE ARCH PARTNERS
3200 ALPINE RD
PORTOLA VALLEY, CA 94028
State of Incorporation
DE
Related Filers
MARK A WAN — 30 joint filings, latest 2018-05-23
Three Arch Management IV, L.L.C. — 17 joint filings, latest 2015-12-16
THREE ARCH MANAGEMENT III LLC — 16 joint filings, latest 2015-12-16
THREE ARCH ASSOCIATES IV LP — 14 joint filings, latest 2018-05-23
Roderick A Young — 2 joint filings, latest 2008-01-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STIM Director 138,563 $2.88 $399.1K $113.3K 11 2023-05-30
CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted Director 0 $8.37 $0 -$9.27M 11 2023-03-06
NEVRO CORP (NVRO) Delisted Director 12,698 $5.84 $74.2K -$103.28M 20 2020-05-26
Molecular Templates, Inc. (THLD) Delisted Director 4,773 — — -$17.52M 27 2016-06-28
TALPHERA, INC. (ACRX) Delisted 10%+ Owner — $0.86 — $0 1 2011-02-18
EPOCRATES INC (EPOC) Delisted 1,655,329 — — -$18.70M 1 2011-02-07
Molecular Templates, Inc. (THLDD) Delisted Director 70,764 — — $2.00M 1 2008-09-03
NORTH AMERICAN SCIENTIFIC INC (NASI) Delisted Director 17,913,296 — — $0 2 2008-05-01

Recent Filings

74 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-05-30 STIM Grant (A) +36,364 $0 EDGAR
2023-03-06 CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted Mixed −21,525 $0 EDGAR
2022-06-13 CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted Grant (A) +16,400 $0 EDGAR
2022-05-31 STIM Grant (A) +38,910 $0 EDGAR
2021-06-11 CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted Grant (A) +5,125 $0 EDGAR
2021-06-01 STIM Grant (A) +7,137 $0 EDGAR
2020-08-07 STIM Grant (A) +18,513 $0 EDGAR
2020-06-12 CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted Grant (A) — $0 EDGAR
2020-05-28 STIM Grant (A) +20,000 $0 EDGAR
2020-05-26 NEVRO CORP (NVRO) Delisted Grant (A) +1,376 $0 EDGAR
Showing 1–10 of 74
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.